The U.S. Food and Drug Administration is moving toward allowing compounding pharmacies to produce more than a dozen injectable peptides that were banned because of potentially significant safety risks, the New York Big FDA review coming this July. Here's what athletes and patients should know about BPC 157, TB 500, and the broader peptide conversation. Always speak with your physician before starting any new protocol. #bpc157 # FDA Moves to Reevaluate Several Peptides American Med Spa Association AP's BPC 157 peptide warning skips every doctor who disagrees Seattle Red Regulatory Alert: The Legal Status of BPC 157 in Compounding and Clinical Practice Holt Law eNavvi Insights